The global flow cytometry immune marker panels market is projected to grow from USD 950 million in 2025 to USD 1,958 million by 2035, at a CAGR of 7.5%. By product type, immunophenotyping panels will lead with a 45% market share, while by application, oncology and CAR-T monitoring will dominate with a 38% share in 2025.